Filing Details
- Accession Number:
- 0001209191-20-064696
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-21 17:52:13
- Reporting Period:
- 2020-12-17
- Accepted Time:
- 2020-12-21 17:52:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1308547 | Dolby Laboratories Inc. | DLB | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1200469 | J Kevin Yeaman | C/O Dolby Laboratories, Inc. 1275 Market Street San Francisco CA 94103 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2020-12-17 | 5,082 | $91.03 | 106,414 | No | 4 | F | Direct | |
| Class A Common Stock | Disposition | 2020-12-18 | 5,168 | $92.07 | 38,252 | No | 4 | S | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 43,420 | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Footnotes
- In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units.
- Shares held following the reported transactions include 106,414 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
- This transaction was executed in multiple trades at prices ranging from $91.48 to $92.43, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
